3.26
-0.02(-0.61%)
Currency In USD
| Previous Close | 3.28 |
| Open | 3.29 |
| Day High | 3.32 |
| Day Low | 3.2 |
| 52-Week High | 4.39 |
| 52-Week Low | 2.11 |
| Volume | 40,542 |
| Average Volume | 51,459 |
| Market Cap | 276.12M |
| PE | -6.79 |
| EPS | -0.48 |
| Moving Average 50 Days | 3.09 |
| Moving Average 200 Days | 2.94 |
| Change | -0.02 |
If you invested $1000 in Alpha Tau Medical Ltd. (DRTS) since IPO date, it would be worth $322.77 as of August 18, 2025 at a share price of $3.26. Whereas If you bought $1000 worth of Alpha Tau Medical Ltd. (DRTS) shares 3 years ago, it would be worth $336.43 as of August 18, 2025 at a share price of $3.26.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Alpha Tau to Present at Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:30 PM GMT
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present a
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
GlobeNewswire Inc.
May 12, 2025 8:01 PM GMT
JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, the Presiden
Alpha Tau to Participate in May Investor Conferences
GlobeNewswire Inc.
May 06, 2025 12:30 PM GMT
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentat